
|Articles|December 4, 2015
New Biosimilar Under Review in Top Specialty Pharmacy News
Author(s)Davy James, Managing Editor
Catch up with any news you missed this week on Specialty Pharmacy Times.
Advertisement
[<a href="//storify.com/pharmacytimes/new-biosimilar-under-review-in-top-specialty-pharm" target="_blank">View the story "New Biosimilar Under Review in Top Specialty Pharmacy News" on Storify</a>]
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
TrumpRx Launches, Offering Cash-Paying Patients Discounted Drugs
2
Pharmacist Takeover: CAR T Therapy Signals a Shift in ALL Treatment
3
SGLT2 Inhibitors in T2D Lower 5-Year Risk of CKD and Acute Kidney Injury
4
Q&A: Making Plant-Based Eating Practical in Pharmacy-Led Cardiometabolic Care
5


























